Intracranial aneurysms in pediatric population treated with flow diverters: A single-center experience

Jorge Arturo Santos-Franco1, Carlos Antonio Cruz-Argüelles1, Fernando Agustin-Aguilar1

  • 1Department of Neurosurgery, Hospital de Especialidades, Centro Médico Nacional La Raza, Mexico City, Mexico.

Insights

Flow diverters (FDs) effectively treat selected pediatric intracranial aneurysms (PIAs), showing stable occlusion in 90% of patients over a year. This study highlights FDs as a viable option for these rare pediatric vascular conditions.

Area of Science:

  • Neuroendovascular surgery
  • Pediatric neurosurgery
  • Vascular neurology

Background:

  • Pediatric intracranial aneurysms (PIAs) are rare cerebrovascular conditions.
  • Flow diverters (FDs) are an emerging endovascular treatment option for aneurysms.

Purpose of the Study:

  • To evaluate the safety and efficacy of flow diverters in treating pediatric intracranial aneurysms.
  • To assess outcomes and imaging follow-up in pediatric patients treated with FDs.

Main Methods:

  • Retrospective case series of 10 pediatric patients treated with FDs.
  • Data collected on patient demographics, aneurysm characteristics, treatment, and follow-up.
  • Imaging follow-up included CT angiography and DSA at regular intervals.

Main Results:

  • 10 pediatric patients (4.3% of total FD-treated patients) with PIAs were treated.
  • Presenting symptoms included subarachnoid hemorrhage, epilepsy, cranial nerve compression, and headache.
  • 90% of patients achieved stable aneurysm occlusion at a minimum 1-year follow-up.

Conclusions:

  • Flow diverters are a potentially effective treatment for carefully selected pediatric intracranial aneurysms.
  • This small series demonstrates favorable outcomes with sustained aneurysm occlusion.
Abstract